Experimental Trypanosoma cruzi infection in platelet-activating factor receptor-deficient mice

被引:21
|
作者
Talvani, A
Santana, G
Barcelos, LS
Ishii, S
Shimizu, T
Romanha, AJ
Silva, JS
Soares, MBP
Teixeira, MM
机构
[1] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil
[2] Univ Tokyo, Dept Biochem & Mol Biol, Fac Med, Tokyo, Japan
[3] Japan Sci & Technol Corp, CREST, Tokyo, Japan
[4] Fiocruz MS, Ctr Pesquisas Rene Rachou, BR-30190 Belo Horizonte, MG, Brazil
[5] Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, SP, Brazil
[6] Fiocruz MS, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil
关键词
platelet-activating factor; protozoan infection; inflammation; chemokines; TNF-alpha; knockout;
D O I
10.1016/S1286-4579(03)00146-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The generation of an inflammatory response driven by Trypanosoma cruzi or its subproducts appears to be essential for tissue injury and disease pathogenesis. However, this inflammatory response is also relevant in the control of T. cruzi replication. The lipid mediator platelet-activating factor (PAF) has been implicated in a number of pathological conditions characterized by tissue inflammation. In the present study, we aimed at evaluating the role of PAF during T cruzi infection by using mice that were genetically deficient in the PAF receptor. We observed that infected hearts of PAFR(-/-) mice had tin increased number of parasite nests, associated with a more intense inflammatory infiltrate. This was associated with greater parasitemia and lethality. When wild-type and PAFR(-/-) mice were compared, there were no marked changes in the kinetics of the expression of MCP-1, RANTES, IFN-/- and TNF-alpha in heart tissue of infected animals. Moreover, serum concentrations of TNF-alpha, nitrate and parasite-specific IgM were similar in both groups of mice. In vitro, macrophages from PAFR(-/-) animals did not phagocytose trypomastigote forms when activated with PAF, leukotriene B-4 or MCP-1 and produced less nitric oxide when infected and activated with IFN-gamma. These results are consistent with the hypothesis that endogenous synthesis of PAF and activation of PAF receptors control T. cruzi replication in mice in great part via facilitation of the uptake of the parasite and consequent activation of macrophages. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:789 / 796
页数:8
相关论文
共 50 条
  • [21] Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy
    Musto, Alberto E.
    Samii, Mark
    EPILEPSIA, 2011, 52 (03) : 551 - 561
  • [22] Deficient platelet-activating factor and related enzymes in hemimegalencephaly
    Hirashima, Y
    Endo, S
    Karasawa, K
    Sato, N
    Yokoyama, K
    Kurimoto, M
    Ikeda, H
    Setaka, M
    Takaku, A
    CHILDS NERVOUS SYSTEM, 1999, 15 (2-3) : 98 - 101
  • [23] Trypanosoma cruzi infection in Cyclophilin D deficient mice
    Milduberger, Natalia
    Bustos, Patricia L.
    Gonzalez, Carolina
    Perrone, Alina E.
    Postan, Miriam
    Bua, Jacqueline
    EXPERIMENTAL PARASITOLOGY, 2021, 220
  • [24] Platelet-Activating Factor Receptor Is Essential for the Development of Experimental Cerebral Malaria
    Lacerda-Queiroz, Norinne
    Rodrigues, David H.
    Vilela, Marcia C.
    Rachid, Milene A.
    Soriani, Frederico M.
    Sousa, Lirlandia P.
    Campos, Roberta D. L.
    Quesniaux, Valerie F. J.
    Teixeira, Mauro M.
    Teixeira, Antonio L.
    AMERICAN JOURNAL OF PATHOLOGY, 2012, 180 (01): : 246 - 255
  • [25] Deficient platelet-activating factor and related enzymes in hemimegalencephaly
    Y. Hirashima
    Shunro Endo
    Kenn Karasawa
    Noriko Sato
    Kazuaki Yokoyama
    Masanori Kurimoto
    Hiroaki Ikeda
    Morio Setaka
    Akira Takaku
    Child's Nervous System, 1999, 15 : 98 - 101
  • [26] The vascular distribution of the platelet-activating factor receptor
    Predescu, D
    Ihida, K
    Predescu, S
    Palade, GE
    EUROPEAN JOURNAL OF CELL BIOLOGY, 1996, 69 (01) : 86 - 98
  • [27] Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice
    Ishii, S
    Shimizu, T
    PROGRESS IN LIPID RESEARCH, 2000, 39 (01) : 41 - 82
  • [28] Targeting Trypanosoma cruzi Platelet-activating Factor Receptors: Scope for the Development of Novel Drugs to Treat Chagas Disease
    Kawano, Daniel Fabio
    Carvalho, Ivone
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2013, 13 (07) : 997 - 1004
  • [29] Platelet-activating factor and platelet-activating factor antagonists in acute pancreatitis
    Johnson, CD
    DIGESTIVE SURGERY, 1999, 16 (02) : 93 - 101
  • [30] Hypersusceptibility to invasive pneumococcal infection in experimental sickle cell disease involves platelet-activating factor receptor
    Miller, Martha L.
    Gao, Geli
    Pestina, Tamara
    Persons, Derek
    Tuomanen, Elaine
    JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (04): : 581 - 584